From the FDA.
- Published in:
- Brown University Psychopharmacology Update, 2013, v. 24, n. 12, p. 8
- Publication type:
- Article
Works matching IS 10685308 AND DT 2013 AND VI 24 AND IP 12
Results: 11
1
2
Gabapentin reduces opiate use during withdrawal protocol.
- Published in:
- Brown University Psychopharmacology Update, 2013, v. 24, n. 12, p. 8
- Publication type:
- Article
3
Semagacestat trial for Alzheimer's halted amid adverse events.
- Published in:
- Brown University Psychopharmacology Update, 2013, v. 24, n. 12, p. 8
- Publication type:
- Article
4
Symptoms, not antipsychotics, linked to Alzheimer's admissions.
- Published in:
- Brown University Psychopharmacology Update, 2013, v. 24, n. 12, p. 8
- Publication type:
- Article
5
Intermittent antipsychotic treatment not as effective as continuous.
- Published in:
- Brown University Psychopharmacology Update, 2013, v. 24, n. 12, p. 7
- Publication type:
- Article
6
Escitalopram has preventive effect in head and neck cancer patients.
- Published in:
- Brown University Psychopharmacology Update, 2013, v. 24, n. 12, p. 7
- Publication type:
- Article
7
Adjunctive therapies in schizophrenia have little effect on cognition.
- Published in:
- Brown University Psychopharmacology Update, 2013, v. 24, n. 12, p. 3
- Publication type:
- Article
8
Adverse reaction to antibiotic in patient receiving venlafaxine.
- Published in:
- 2013
- By:
- Publication type:
- Case Study
9
Fluoxetine, cognitive therapy both mitigate relapse in high-risk group.
- Published in:
- Brown University Psychopharmacology Update, 2013, v. 24, n. 12, p. 1
- Publication type:
- Article
10
Controlled trial finds ketamine exerts rapid antidepressant effects.
- Published in:
- Brown University Psychopharmacology Update, 2013, v. 24, n. 12, p. 1
- Publication type:
- Article
11
Postpartum hemorrhage shows higher incidence in antidepressant users.
- Published in:
- Brown University Psychopharmacology Update, 2013, v. 24, n. 12, p. 4
- Publication type:
- Article